GalenOps prod · 0.1.0

Patient

SITE012-0169

enrolled Phase III

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE012 (BRA) (Dr. Kowalski)

consented 2026-03-19

SITE012 (BRA)

Adverse events

9

Serious AEs

0

Open data queries

0

Luna dropout signal

—

not on Luna

Adverse events 9

moderate assessed 2026-09-01

Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2023-02-25 (study day 151); relationship: not assessed

moderate assessed 2026-08-28

Grade 2 Alopecia — outcome: UNKNOWN; onset 2023-02-21 (study day 147); relationship: not assessed

moderate assessed 2026-07-13

Grade 2 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2023-01-06 (study day 101); relationship: not assessed

mild assessed 2026-06-21

Grade 1 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-12-15 (study day 79); relationship: not assessed

severe assessed 2026-06-13

Grade 3 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-12-07 (study day 71); relationship: RELATED

severe assessed 2026-05-17

Grade 3 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2022-11-10 (study day 44); relationship: not assessed

moderate assessed 2026-04-24

Grade 2 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-10-18 (study day 21); relationship: not assessed

moderate assessed 2026-04-17

Grade 2 Asthenia — outcome: RECOVERED/RESOLVED; onset 2022-10-11 (study day 14); relationship: not assessed

mild assessed 2026-04-08

Grade 1 Constipation — outcome: RECOVERED/RESOLVED; onset 2022-10-02 (study day 5); relationship: not assessed

Data queries 0

No data queries

The CDM sweep raises queries on inconsistent fields.

Luna engagement

This participant doesn't use Luna

Invite them from the site to track mood, adherence and check-ins.

Open Luna users